Published in Ann Thorac Surg on April 01, 2007
Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery. Circulation (2015) 3.25
Shop for quality or volume? Volume, quality, and outcomes of coronary artery bypass surgery. Ann Intern Med (2009) 2.67
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Case volume, quality of care, and care efficiency in coronary artery bypass surgery. Arch Intern Med (2010) 1.53
What are the odds? Ann Thorac Surg (2007) 1.47
The impact of high-risk cases on hospitals' risk-adjusted coronary artery bypass grafting mortality rankings. Ann Thorac Surg (2015) 1.38
Perfusion quality improvement and the reduction of clinical variability. J Extra Corpor Technol (2009) 1.07
Learning by doing, scale effects, or neither? Cardiac surgeons after residency. Health Serv Res (2009) 1.01
Composite measures for rating hospital quality with major surgery. Health Serv Res (2012) 1.00
Postoperative mortality is an inadequate quality indicator for lung cancer resection. Ann Thorac Surg (2014) 0.92
Analyzing "failure to rescue": is this an opportunity for outcome improvement in cardiac surgery? Ann Thorac Surg (2013) 0.84
European institutional accreditation of general thoracic surgery. J Thorac Dis (2014) 0.84
Provider-hospital "fit" and patient outcomes: evidence from Massachusetts cardiac surgeons, 2002-2004. Health Serv Res (2010) 0.83
Appraising the quality of care in surgery. World J Surg (2009) 0.78
Epidemiology of coronary artery bypass grafting at the Hospital Beneficência Portuguesa, São Paulo. Rev Bras Cir Cardiovasc (2015) 0.78
Utilisation of blood components in cardiac surgery: a single-centre retrospective analysis with regard to diagnosis-related procedures. Transfus Med Hemother (2015) 0.77
Surgical Quality Predicts Length of Stay in Patients with Congenital Heart Disease. Pediatr Cardiol (2016) 0.76
The dangers of gathering data: surgeon-specific outcomes revisited. Int J Angiol (2011) 0.75
Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry. J Am Heart Assoc (2012) 0.75
Surgical tourism: the role of cardiothoracic surgery societies in evaluating international surgery centers. Ann Thorac Surg (2013) 0.75
Risk Prediction in Aortic Valve Replacement: Incremental Value of the Preoperative Echocardiogram. J Am Heart Assoc (2015) 0.75
Significance of preoperative total lymphocyte count as a prognostic criterion in adult cardiac surgery. Anesth Pain Med (2014) 0.75
An innovative new concept for quality measurement in adult cardiac surgery. Ann Thorac Surg (2007) 0.75
Improving Indicators in a Brazilian Hospital Through Quality-Improvement Programs Based on STS Database Reports. Braz J Cardiovasc Surg (2015) 0.75
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Screening for serious mental illness in the general population. Arch Gen Psychiatry (2003) 15.75
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00
Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78
Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes (2009) 5.66
Pay for performance in commercial HMOs. N Engl J Med (2006) 5.52
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation (2006) 5.35
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg (2007) 5.32
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg (2011) 4.84
Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation (2007) 4.74
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation (2006) 4.52
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17
Physician clinical performance assessment: prospects and barriers. JAMA (2003) 4.16
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg (2009) 4.10
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ (2005) 3.94
Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
Behavioral health insurance parity for federal employees. N Engl J Med (2006) 3.77
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med (2002) 3.77
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA (2005) 3.72
Conversion of cardiovascular conference abstracts to publications. Circulation (2012) 3.71
Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71
Procedural volume as a marker of quality for CABG surgery. JAMA (2004) 3.70
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
Variability in the measurement of hospital-wide mortality rates. N Engl J Med (2010) 3.65
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol (2009) 3.54
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA (2011) 3.44
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39